BEND, Ore.--(BUSINESS WIRE)--Amplion, developer of BiomarkerBase™, the industry’s leading platform for researching biomarkers in clinical use and development, announces today that BiomarkerBase™ is now the first and only database that includes biomarkers in Laboratory-Developed Tests (LDTs).
“Laboratory-developed tests represent the segment of the testing market where most of the innovation has taken place over the last decade,” said John Audette, CEO of Amplion. “Being able to analyze biomarkers used in LDTs, alongside biomarkers in FDA-approved tests, drug labels, and clinical trials, is a capability our customers in biopharma and diagnostics have been requesting for some time.”
Help employers find you! Check out all the jobs and post your resume.
